Belén Garijo (Almansa, 1960) is the CEO of the German giant Merck, which is valued at 240,000 million on the stock market, like Inditex and Banco Santander combined.

Merck KGaA (OTCPK:MKGAF) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - CEO of the Group Marcus Kuhnert ...

Belen Garijo took charge of German drug-to-semiconductor group Merck KGaA with the tailwind of the Covid pandemic, propelling the stock to an all-time high in 2021. Since then, the shares have ...

The transaction, finalized following regulatory clearance, includes two FDA-approved rare tumor therapies: Ogsiveo for ...

Pharm Exec speaks with Spanish-born Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany’s healthcare business, who shares her steady-eyed approach in transforming a traditional pharma unit focused on ...

MERCK Kommanditgesellschaft auf Aktien. (OTCPK:MKGAF) Q1 2021 Results Earnings Conference Call May 12, 2021 8:00 AM ETCompany ParticipantsConstantin Fest - ...

CARY, N.C., March 25, 2021 /PRNewswire/ -- The CEO Roundtable on Cancer has elected to its Board of Directors Dr. Belén Garijo, Vice Chair of the Executive Board and Deputy CEO of Merck KGaA ...

Belen Garijo, the Spanish CEO of the German drugmaker and manufacturer of lab equipment and semiconductor chemicals, said late on Monday that dependencies between the powers were huge, speaking at ...

Belen Garijo has taken over as CEO at German pharmaceuticals giant Merck -- the first woman to singlehandedly run a DAX 30-listed company -- as Europe's top economy debates quotas for greater ...

German pharmaceutical giant Merck has completed a €3 billion ($3. 5 billion) takeover of US biopharmaceutical company ...

RELATED: Top women in biopharma 2015 | Belén Garijo, Merck KGaA During her tenure as CEO of Merck Healthcare, the company made several strategic moves, including divesting its biosimilar ...